IL6 and Gliosis: The authors demonstrated that IL-6(−/−) mice subjected to a repeated METH treatment (5 or 10 mg/kg; four times at 2 h intervals, i.p.)showed less depletion of dopamine levels and its transporter binding, a reduction in serotonin levels, and also inhibition of gliosis, when compared with wild-type mice [36].